These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 24145218)

  • 21. Screening for depression in epilepsy clinics. A comparison of conventional and visual-analog methods.
    Rampling J; Mitchell AJ; Von Oertzen T; Docker J; Jackson J; Cock H; Agrawal N
    Epilepsia; 2012 Oct; 53(10):1713-21. PubMed ID: 22765759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study.
    Mitsonis CI; Dimopoulos NP; Mitropoulos PA; Kararizou EG; Katsa AN; Tsakiris FE; Katsanou MN
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):373-7. PubMed ID: 17092620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the Insomnia in the Elderly Scale for the detection of insomnia in older adults.
    Navarro B; López-Torres J; Andrés F; Latorre JM; Montes MJ; Párraga I
    Geriatr Gerontol Int; 2013 Jul; 13(3):646-53. PubMed ID: 23171440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].
    Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G;
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quetiapine use in a patient with chronic schizophrenia and severe parkinsonism.
    Stoner SC; Lea JW; Wolf AL; Berges AA
    Pharmacotherapy; 2005 Nov; 25(11):1651-5. PubMed ID: 16232027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge.
    Merello M; Gerschcovich ER; Ballesteros D; Cerquetti D
    Parkinsonism Relat Disord; 2011 Nov; 17(9):705-7. PubMed ID: 21784692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
    Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Easy and low-cost identification of metabolic syndrome in patients treated with second-generation antipsychotics: artificial neural network and logistic regression models.
    Lin CC; Bai YM; Chen JY; Hwang TJ; Chen TT; Chiu HW; Li YC
    J Clin Psychiatry; 2010 Mar; 71(3):225-34. PubMed ID: 19814949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.
    Merello M; Nouzeilles MI; Arce GP; Leiguarda R
    Mov Disord; 2002 Jul; 17(4):795-8. PubMed ID: 12210878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S; Dollfus S; Lesieur P; Petit M
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
    Lejoyeux M; Gorwood P; Stalla-Bourdillon A; Adès J
    Encephale; 1993; 19(1):17-21. PubMed ID: 8275889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Parkinsonian gait in older adults with dementia via human pose tracking in video data.
    Sabo A; Mehdizadeh S; Ng KD; Iaboni A; Taati B
    J Neuroeng Rehabil; 2020 Jul; 17(1):97. PubMed ID: 32664973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cocaine is a major risk factor for antipsychotic induced akathisia, parkinsonism and dyskinesia.
    Maat A; Fouwels A; de Haan L
    Psychopharmacol Bull; 2008; 41(3):5-10. PubMed ID: 18779773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SCOPA-cognition cutoff value for detection of Parkinson's disease dementia.
    Verbaan D; Jeukens-Visser M; Van Laar T; van Rooden SM; Van Zwet EW; Marinus J; van Hilten JJ
    Mov Disord; 2011 Aug; 26(10):1881-6. PubMed ID: 21542025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.
    Schennach-Wolff R; Meyer S; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ; Riedel M
    J Psychiatr Res; 2011 Dec; 45(12):1639-47. PubMed ID: 21862035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroanatomical pattern classification in a population-based sample of first-episode schizophrenia.
    Zanetti MV; Schaufelberger MS; Doshi J; Ou Y; Ferreira LK; Menezes PR; Scazufca M; Davatzikos C; Busatto GF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():116-25. PubMed ID: 23261522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders.
    Peralta V; Basterra V; Campos MS; de Jalón EG; Moreno-Izco L; Cuesta MJ
    Eur Arch Psychiatry Clin Neurosci; 2012 Mar; 262(2):131-8. PubMed ID: 21626260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.